KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Change in Accured Expenses (2016 - 2026)

Edwards Lifesciences has reported Change in Accured Expenses over the past 17 years, most recently at $168.7 million for Q4 2025.

  • For Q4 2025, Change in Accured Expenses rose 5541.94% year-over-year to $168.7 million; the TTM value through Dec 2025 reached $395.1 million, up 341.45%, while the annual FY2025 figure was $395.1 million, 341.45% up from the prior year.
  • Change in Accured Expenses for Q4 2025 was $168.7 million at Edwards Lifesciences, down from $226.1 million in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $226.1 million in Q3 2025 and troughed at -$109.2 million in Q1 2022.
  • A 5-year average of $40.2 million and a median of $32.2 million in 2021 define the central range for Change in Accured Expenses.
  • Biggest five-year swings in Change in Accured Expenses: crashed 1074.19% in 2022 and later surged 5541.94% in 2025.
  • Year by year, Change in Accured Expenses stood at $31.1 million in 2021, then rose by 10.29% to $34.3 million in 2022, then fell by 2.62% to $33.4 million in 2023, then crashed by 109.28% to -$3.1 million in 2024, then surged by 5541.94% to $168.7 million in 2025.
  • Business Quant data shows Change in Accured Expenses for EW at $168.7 million in Q4 2025, $226.1 million in Q3 2025, and $103.7 million in Q2 2025.